Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 207
How single-cell genomics is revolutionizing cancer research
Nicholas E. Navin
UT MD Anderson Cancer Ctr., Bellaire, TX, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Deciphering selection in lung cancer evolution
Thomas Watkins
The Francis Crick Institute, London, United Kingdom
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Insights into cancer evolution and selection from whole genome sequencing studies?
Peter J. Campbell
Wellcome Trust Sanger Inst., Cambridge, United Kingdom
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Advances in analytical methods for clonal evolution inference at single-cell and bulk resolution
Sohrab Shah
BC Cancer Agency Vancouver Ctr., Vancouver, BC, Canada
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
The broad cell line factory: Developing early passage cell lines for cancer biology and drug development
Jesse S. Boehm
Broad Institute, Cambridge, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Utility of patient-derived xenograft models to mirror precision oncology clinical trials
James H. Doroshow
NCI-DCTD, Bethesda, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Pharmacodynamic modeling to predict biologically effective drug dosing
Ralph E. Parchment
Frederick National Laboratory/SAIC-Frederick, Inc., Frederick, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Spontaneous canine malignancies: Models for precision cancer medicine
Amy K Leblanc
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Design and outcome data from molecularly-targeted basket trials
Edith A. Perez
Genentech, Inc., South San Francisco, CA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
How NCI collaborates with Pharma and Academic Investigators: Clinical Development Plan for Osimertinib as a Case Study
Jeffrey A. Moscow
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Update of biomarker prevalence identified by next generation sequencing
Siraj M Ali
Foundation Medicine, Cambridge, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Novel clinical trial designs for targeted agents
Mithat Gonen
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Illuminating the tumor microenvironment using single and multiplex immunohistochemistry
Janis Marie Taube
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Next-generation pathology: Quantitative immunofluorescence and imaging mass cytometry
Kurt Alex Schalper
Yale Univ., New Haven, CT, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Tissue-based genomic biomarkers for immunotherapy
Matthew David Hellmann
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
The MANA functional expansion of specific T cells (MANAFEST) assay: A sensitive molecular approach for clinical monitoring of peripheral anti-tumor immunity
Kellie N Smith
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Gene dysregulation in cancer: The view from chromosome neighborhoods
Richard A. Young
MIT Whitehead Inst. for Biomed. Research, Cambridge, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Histone modifications and gene expression in cancer
Scott A. Armstrong
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
ATP-dependent chromatin remodeling complexes in human cancer
Cigall Kadoch
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Enhancer reprogramming during cancer progression
Christopher R. Vakoc
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Lessons and opportunities for probe development in cancer research
David E. Uehling
Ontario Inst. for Cancer Research, Toronto, ON, Canada
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Value proposition of chemical probes in the development of translational phenotypic bioassays towards target discovery and validation
Ivan Cornella-Taracido
Merck & Co., Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Chemical probes of chromatin regulation: Case histories
Stephen V. Frye
Univ. of North Carolina at Chapel Hill, Chapel Hill, NC, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Mechanism and therapeutic application of RNA-guided immune systems
Christof Fellmann
UC Berkeley, Berkeley, CA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Retooling CRISPR to turn genes on and off
Luke A. Gilbert
UCSF, San Francisco, CA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 207